Studies involving guaraná show benefits to cognitive function. They have not been evaluated by the Food and Drug Administration (FDA) or any similar government agencies. In the United States, guaraná holds a GRAS-status, i.e. "generally regarded as safe" and must be labeled as "not intended to diagnose, treat, cure or prevent any disease."